Adam Harris
Adult Reconstructive Orthopaedic Surgery · San Antonio, TXNPI 1114905478
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 99.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $55,976 and has fallen 99.6% since, to $214 in 2025.
Across 65 payments — averaging $1006.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$65K
- Brixton Biosciences, Inc.$143
- Takeda Pharmaceuticals U.S.A., Inc.$90
- Alafair Biosciences, Inc.$85
- Vertex$54
- Baxter Healthcare$49
- plus $135 from 7 others
Across 23 payments — averaging $2379.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Brixton Biosciences, Inc.$33K
- Smith+Nephew$21K
What the payments were for
- Consulting fees$38,62559%
- Speaking & faculty fees$21,25032%
- Travel & lodging$3,3525%
- Food & beverage$2,2193%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 49 | $64,890 |
| Brixton Biosciences, Inc. | 1 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $90 |
| Alafair Biosciences, Inc. | 1 | $85 |
| Vertex | 2 | $54 |
| Baxter Healthcare | 1 | $49 |
| KCI USA, Inc. | 1 | $29 |
| Johnson & Johnson | 1 | $28 |
| Convatec Inc. | 2 | $28 |
| Fidia Pharma USA Inc. | 1 | $16 |
| Bioventus LLC | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Heron Therapeutics, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II BCS$35,000
- Journey II XR$27,099
- Journey II CR$13,875
- JII Unicondylar Knee System$10,875
- Journey II$9,461
- Journey Uni$6,390
- REAL INTELLIGENCE$5,585
- Navio Surgical System$5,048
- LEGION TKS$750
- Oxinium Hips$500
- VERILAST Hips$500
- POLARSTEM$500
- VISIONAIRE Solutions$500
- VISIONAIRE Cutting Guides$276
- Legion$253
- PICO 7 Single Use Negative Pressure Wound Therapy$147
- REGENESORB$147
- Neural Ice$143
- Legion Revision$132
- Legion Hinge$132
How this compares
$65,445 in reported general payments places this provider in the 75th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.
See all adult reconstructive orthopaedic surgery providers in Texas →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 63 | $883 |
| Naproxen | 41 | $271 |
| Amoxicillin | 92 | $167 |
| Azithromycin | 23 | $69 |
| Meloxicam | 12 | $33 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in San Antonio
- Zachary ClarkeSan Antonio$16K
- Donald HopeSan Antonio$13K
- Tyler GoldbergAustin$4.6M
- Antonia ChenDallas$3.8M
- John BarringtonPlano$2.2M
- Roger EmersonPlano$691K
- Donald HohmanDallas$537K
- Steven WeedenFort Worth$370K
- Marcus FordFort Worth$296K
- Raul MarquezEdinburg$278K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.